Posts tagged ‘Timothy Wilson’

Urologic cancers: Dispatches from research’s front lines

March 28, 2014 | by
African American men are 60 percent more likely than white men to get prostate cancer and 2.4 times more likely to die of the disease.
Urologic cancers, including prostate cancer, kidney cancer and bladder cancer, are diagnosed in more than 381,000 Americans each year, and almost 60,000 people die from the diseases. City of Hope’s physicians and scientists are determined to reduce those numbers. Our groundbreaking research holds the promise of better treatments and cures for the millions of people worldwide battling these difficult cancers. The Division of Urology and Urologic Oncology, led by Timothy Wilson, M.D., Pauline & Martin Collins Family Chair in Urology and director of the Prostate Cancer Program, report the following developments in the treatment of urologic cancers. **…

Cancer treatment in 2014: Making the most of research

December 29, 2013 | by
Fighting cancer
Cancer will be defeated not in one enormous advance, experts agree, but in incremental advances. Those incremental advances often go unnoticed by the public at the time of their discovery, but in the years to come, they add up – to more life years, to greater survival rates, to more time spent with families and loved ones. In 2014, patients will begin to see the benefits of many of those advances. Here, City of Hope’s physicians describe some of the recent scientific and medical developments they expect to benefit patients in the year ahead. Breast cancer: A…

Prostate cancer abstract: So few words, so much impact

May 3, 2013 | by
Prostate cancer, illustrated here, doesn't always need immediate treatment. The dilemma is trying to decide when "active surveillance" is all that's necessary. A new abstract, from researchers at City of Hope, could help doctors and patients decide.
The title was this: “Expressed Prostatic Secretions Biomarkers Improve Stratification of National Comprehensive Cancer Network Active Surveillance Candidates.” Prostate cancer, illustrated here, doesn’t always need immediate treatment. The dilemma is trying to decide when “active surveillance” is all that’s necessary. A new abstract, from researchers at City of Hope, could help doctors and patients decide. And the conclusions were these: “Secondary screening by non-invasive EPS testing may improve patient acceptance of Active Surveillance by dramatically reducing the presence of occult risk factors in patients eligible for Active Surveillance under NCCN guidelines.” In between were the…

‘My cancer diagnosis: What I wish I’d known’ – Bill Brutocao

January 8, 2013 | by
Bill Brutocao, a former Hodgkin lymphoma patient
One in a series of stories asking former patients to reflect upon their experience … Soon after beginning treatment for prostate cancer at City of Hope in 2008, La Canada attorney Bill Brutocao received even more disturbing news. He was diagnosed with Hodgkin lymphoma. Former Hodgkin lymphoma patient Bill Brutocao, second from left, advises cancer patients not to become prima donnas. Cancer is hard on one’s family too, he says. He’s shown here with, from left, son Angelo, wife Christina, son Giancarlo and Giancarlo’s wife, Laura. (Photo courtesy Bill Brutocao) Under the supervision of physicians Kevin Chan,…

I, for one, welcome our new robot overlords … uh, surgeons

August 21, 2012 | by
Photo of minimally invasive robotic surgery
For such a small gland, the prostate stirs up a lot of debate. It seems that every month brings a new study that raises questions about how best to detect, diagnose and treat prostate cancer. And it’s that time again. Clayton Lau, right, during a minimally invasive robotic surgery. (Photo by Alicia Di Rado) This time it’s about the best way to operate. When a prostate cancer patient chooses to have his cancer removed through an operation, he has a few options: a traditional open surgery, where the surgeon makes an incision across the patient’s…

How do you take the measure of a man?

May 17, 2012 | by
Warren Buffett’s recent revelation about his prostate cancer diagnosis re-opened the debate over age and prostate cancer screening and treatment. At 81, Buffett falls outside of the commonly used guidelines that men over 75 don’t need to be screened for prostate cancer. The United States Preventive Services Task Force made this recommendation in 2008, noting that most men over age 75 who develop prostate cancer die from other causes. Since prostate cancer in older men tends to develop slowly, experts say, these men do not need treatment that can cause incontinence and other side effects.…

Why should men care about prostate cancer?

October 10, 2011 | by
Timothy Wilson, M.D.
Timothy Wilson, M.D., Director, Prostate Cancer Program and Chief of the Division of Urology and Urologic Oncology Cancers at City of Hope, discusses why men should pay attention to prostate cancer, why screening is important, and outlines the many options and dispels fears about treatment side effects.